Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$0.25 - $11.7 $64,689 - $3.03 Million
-258,757 Reduced 17.89%
1,187,957 $263,000
Q2 2022

Aug 12, 2022

SELL
$0.3 - $1.31 $71,002 - $310,044
-236,675 Reduced 14.06%
1,446,714 $434,000
Q1 2022

May 13, 2022

SELL
$0.61 - $1.84 $292,180 - $881,332
-478,985 Reduced 22.15%
1,683,389 $2.32 Million
Q4 2021

Feb 14, 2022

SELL
$1.16 - $2.74 $119,591 - $282,483
-103,096 Reduced 4.55%
2,162,374 $2.62 Million
Q3 2021

Nov 12, 2021

BUY
$2.62 - $5.43 $161,027 - $333,733
61,461 Added 2.79%
2,265,470 $5.94 Million
Q2 2021

Aug 13, 2021

BUY
$5.06 - $8.15 $11.2 Million - $18 Million
2,204,009 New
2,204,009 $11.7 Million

Others Institutions Holding KALA

# of Institutions
1
Shares Held
1
Call Options Held
0
Put Options Held
0

About Kala Pharmaceuticals, Inc.


  • Ticker KALA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,464,160
  • Market Cap $8.67M
  • Description
  • Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...
More about KALA
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.